[Patients compliance with antibiotherapy of respiratory tract infections]
- PMID: 14575018
[Patients compliance with antibiotherapy of respiratory tract infections]
Abstract
Non-compliance frequently occurs during outpatient antibiotherapy of respiratory tract infections. The most frequent form of non-compliance in such circumstances is omittion of single doses. Patient non-compliance during antibiotherapy is of practical importance. It leads to therapy failure, need of additional health services, growth of direct and indirect therapy cost and development of resistant strains. This paper summarises the methods of evaluating compliance and the results of research on compliance during antibiotherapy of respiratory tract infections. The reasons of patient non-compliance as well as the factors influencing this phenomenon are reviewed. Practical methods of augmenting compliance are suggested with particular stress on the relationship between dosage frequency and compliance. It should be remembered that when the antibiotic is needed for respiratory tract infections treatment, once daily dosing ensures the best possible compliance.
Similar articles
-
Comparison of patient compliance with once-daily and twice-daily antibiotic regimens in respiratory tract infections: results of a randomized trial.J Antimicrob Chemother. 2007 Mar;59(3):531-6. doi: 10.1093/jac/dkl528. Epub 2007 Feb 8. J Antimicrob Chemother. 2007. PMID: 17289766 Clinical Trial.
-
[Patient compliance in the treatment of respiratory tract infections].Lijec Vjesn. 1997 Jul;119(7):193-200. Lijec Vjesn. 1997. PMID: 9471478 Croatian.
-
Dose timing and patient compliance with two antibiotic treatment regimens for lower respiratory tract infections in primary care.Int J Antimicrob Agents. 2008 Jun;31(6):531-6. doi: 10.1016/j.ijantimicag.2008.01.029. Epub 2008 May 5. Int J Antimicrob Agents. 2008. PMID: 18457936 Clinical Trial.
-
Antibiotic usage for respiratory tract infections in an era of rising resistance and increased cost pressure.Am J Manag Care. 2000 Dec;6(23 Suppl):S1216-21. Am J Manag Care. 2000. PMID: 11187446 Review.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical